These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 3156262)
1. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Langleben D; Reid LM Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262 [TBL] [Abstract][Full Text] [Related]
2. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats]. Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548 [TBL] [Abstract][Full Text] [Related]
3. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension. Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y Respiration; 2006; 73(1):105-12. PubMed ID: 16432296 [TBL] [Abstract][Full Text] [Related]
5. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment. Mathew R; Altura BT; Altura BM Magnesium; 1989; 8(2):110-6. PubMed ID: 2526910 [TBL] [Abstract][Full Text] [Related]
6. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429 [TBL] [Abstract][Full Text] [Related]
7. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]. Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852 [TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912 [TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats. Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069 [TBL] [Abstract][Full Text] [Related]
10. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension. Orlinska U; Olson JW; Gillespie MN Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791 [TBL] [Abstract][Full Text] [Related]
11. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension. Langleben D; Carvalho AC; Reid LM Am Rev Respir Dis; 1986 May; 133(5):789-91. PubMed ID: 3085563 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension. Broderick TL; King TM Med Sci Monit; 2008 Dec; 14(12):BR261-4. PubMed ID: 19043358 [TBL] [Abstract][Full Text] [Related]
13. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension]. Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567 [TBL] [Abstract][Full Text] [Related]